Pharvaris
Tracked across 2 events · 16 articles · First seen May 29, 2026 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Pharvaris, a late-stage biopharmaceutical company, announced the acceptance of one oral presentation and seven flash talk/poster presentations at the European Academy of Allergy and Clinical Immunology Annual Congress 2026 in Istanbul, Turkey, from June 12-15,…
Impact: Pharvaris is the biopharmaceutical company presenting clinical data for its drug deucrictibant at the EAACI Annual Congress 2026, which could positively impact its stock price and market position.
May 29, 2026 · 8 articles
Business
Pharvaris, a late-stage biopharmaceutical company, announced its annual general meeting of shareholders will take place on Friday, June 26, 2026, at 16:00 CEST. All relevant documents and information, including the notice and agenda for the…
Impact: Pharvaris announced its annual general meeting of shareholders, which is a routine corporate governance event for the company.
Jun 11, 2026 · 8 articles
100
Pharvaris announced annual meetingPharvaris announces annual...
95
Pharvaris will present dataPharvaris Presents...
90
Pharvaris announced acceptance European Academy of Allergy and Clinical ImmunologyPharvaris Presents...
NEWSDESK
Track Pharvaris live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard